How protein intake and gut bacteria affect mobility in older adults
The relationship between protein intake, gut microbiome, inflammaging and loss of mobility in older adults
This study is looking at how what older adults eat, especially protein, affects their gut health, inflammation, and ability to move around, with the hope of creating personalized diet plans that better support healthy aging.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pittsburgh at Pittsburgh NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project ID | NIH-10983799 on NIH RePORTER |
What this research studies
This research investigates the connection between protein consumption, gut microbiome health, inflammation, and mobility loss in older adults. The goal is to develop personalized dietary recommendations that cater to the unique nutritional needs of aging individuals, moving away from generic guidelines. By analyzing dietary intake and gut bacteria profiles, the study aims to understand how these factors contribute to healthy aging and functional mobility. Participants may provide dietary data and biological samples to help uncover these relationships.
Who could benefit from this research
Good fit: Ideal candidates for this research are older adults who may be experiencing mobility issues or are at risk of muscle loss.
Not a fit: Patients who are not older adults or those with no mobility concerns may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to tailored dietary guidelines that improve mobility and overall health in older adults.
How similar studies have performed: Previous research has shown promising results in understanding the role of diet and gut microbiome in aging, but this specific approach is relatively novel.
Where this research is happening
Pittsburgh, United States
- University of Pittsburgh at Pittsburgh — Pittsburgh, United States (Active)
Researchers
- Principal investigator: Farsijani, Samaneh — University of Pittsburgh at Pittsburgh
- Study coordinator: Farsijani, Samaneh
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.